- Home
- AENT vs OSUR Comparison
AENT vs OSUR Comparison
Compare AENT & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AENT
- OSUR
- Stock Information
- Founded
- AENT 1990
- OSUR 2000
- Country
- AENT United States
- OSUR United States
- Employees
- AENT N/A
- OSUR N/A
- Industry
- AENT Durable Goods
- OSUR Medical/Dental Instruments
- Sector
- AENT Consumer Discretionary
- OSUR Health Care
- Exchange
- AENT Nasdaq
- OSUR Nasdaq
- Market Cap
- AENT 161.5M
- OSUR 223.0M
- IPO Year
- AENT N/A
- OSUR 1986
- Fundamental
- Price
- AENT $5.21
- OSUR $3.10
- Analyst Decision
- AENT Strong Buy
- OSUR Hold
- Analyst Count
- AENT 1
- OSUR 1
- Target Price
- AENT $10.00
- OSUR $3.00
- AVG Volume (30 Days)
- AENT 46.7K
- OSUR 750.0K
- Earning Date
- AENT 05-15-2025
- OSUR 08-05-2025
- Dividend Yield
- AENT N/A
- OSUR N/A
- EPS Growth
- AENT N/A
- OSUR N/A
- EPS
- AENT 0.23
- OSUR N/A
- Revenue
- AENT $1,072,641,000.00
- OSUR $161,626,000.00
- Revenue This Year
- AENT $4.77
- OSUR N/A
- Revenue Next Year
- AENT N/A
- OSUR $6.20
- P/E Ratio
- AENT $23.36
- OSUR N/A
- Revenue Growth
- AENT N/A
- OSUR N/A
- 52 Week Low
- AENT $1.10
- OSUR $2.36
- 52 Week High
- AENT $11.57
- OSUR $4.92
- Technical
- Relative Strength Index (RSI)
- AENT 68.76
- OSUR 59.68
- Support Level
- AENT $5.17
- OSUR $3.00
- Resistance Level
- AENT $6.37
- OSUR $3.13
- Average True Range (ATR)
- AENT 0.54
- OSUR 0.12
- MACD
- AENT 0.14
- OSUR 0.00
- Stochastic Oscillator
- AENT 65.39
- OSUR 80.65
About AENT Alliance Entertainment Holding Corporation
Alliance Entertainment Holding Corp is a top-tier distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.